-
Abstract Number: PB0845
P2Y receptor antagonists and tyrosine kinase inhibitors reduce oxLDL-mediated procoagulant platelet activity
-
Abstract Number: OC 41.4
PACSIN2 regulates platelet integrin β1 hemostatic function
-
Abstract Number: PB0675
Pain as a Determinant of the Quality of Everyday Functioning of Persons with Haemophilia
-
Abstract Number: PB1204
Paradigm shift in ITP treatment patterns in the era of the COVID-19 pandemic – opportunity to study real world outcomes from an established platform: Update from UK Adult ITP registry.
-
Abstract Number: PB0201
Pathogenic variants in F8 gene – Results from the Brazilian Immune Tolerance (BrazIT) Study
-
Abstract Number: OC 28.2
Pathway-based Rare Variant Burden Analysis Identifies a Role for the Complement System in Purpura Fulminans
-
Abstract Number: PB1318
Patient characteristics associated with all-cause mortality of incident hospitalized pulmonary embolism patients: a nationwide cohort study
-
Abstract Number: PB0506
Patient characteristics associated with arterial thromboembolism in incident hospitalized heart failure patients without other known indications for antithrombotic treatment: A nationwide cohort study
-
Abstract Number: PB0461
Patient outcomes of catheter directed thrombolysis for upper extremity deep vein thrombosis
-
Abstract Number: PB0426
Patients Reporting of Post-Traumatic Stress Disorder After Experiencing Venous Thromboembolic Event
-
Abstract Number: PB0427
Patients Reporting on Relevant Functional Limitations Following an Episode of Venous Thromboembolism: The Post Venous Thromboembolism Functional Scale
-
Abstract Number: PB0780
Patients with multiple myeloma have an increased prevalence of acquired platelet secretion defects and a disbalanced whole blood thrombin generation profile
-
Abstract Number: OC 71.2
PAUSE-2 Randomized Pilot Trial to Compare Two Strategies (PAUSE vs. ASRA) for Perioperative DOAC Management
-
Abstract Number: PB0969
PEBSI – Pulmonary Embolism Bleeding Score Index
-
Abstract Number: PB0239
Pediatric Primary Immune Thrombocytopenia: Observation in Armenia
-
Abstract Number: VPB0285
Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm using Rivaroxaban
-
Abstract Number: PB0813
Performance Evaluation of a VWF Antigen Assay in a Multicenter Study
-
Abstract Number: PB0565
Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Apixaban on the Sysmex CN-3000/CN-6000 Systems
-
Abstract Number: PB0556
Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Rivaroxaban on the Sysmex CN-3000/CN-6000 Systems
-
Abstract Number: PB1183
Performance of a Chromogenic Factor IX Activity Assay in the Recovery of Factor IX Replacement Therapies
-
Abstract Number: OC 60.1
Performance of clinical decision rules for venous thromboembolism in patients with a history of thrombosis
-
Abstract Number: PB1177
Performance of FVIII deficient plasma with VWF in the activity measurement of FVIII replacement products in plasma samples using an OSC assay.
-
Abstract Number: OC 31.1
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the Diagnostic Management of Pulmonary Embolism
-
Abstract Number: PB0809
Performance of the ISTH-BAT bleeding score in a population of newly diagnosed VWD in the U.S. Zimmerman Program
-
Abstract Number: PB0920
Performance of the Thrombogyn and Khorana scores for prediction of venous thromboembolism in ovarian cancer patients after major surgery
-
Abstract Number: PB0464
Peri-operative management of anticoagulation and bleeding in patients undergoing Catheter Directed Thrombolysis for acute iliofemoral Deep Vein Thrombosis
-
Abstract Number: PB0480
Periarticular Hemangioma as a Cause of Chronic Arthropathy due to Hemarthrosis
-
Abstract Number: OC 02.4
Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies
-
Abstract Number: VPB0249
Persistent autoantibodies against Factor XI in a girl with an inborn error of immunity
-
Abstract Number: PB0588
Persistent morphological alterations of endothelial colony-forming cells after 9 months in patients recovered from COVID-19
-
Abstract Number: OC 67.2
Personalized Assessment of the Protein C Pathway Using Endothelial Colony Forming Cells
-
Abstract Number: OC 62.2
Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study
-
Abstract Number: OC 77.4
Pharmacological targeting of GPV in a novel humanized mouse model to modulate thrombus formation in vivo
-
Abstract Number: PB1357
Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study
-
Abstract Number: OC 73.2
Phascolarctobacterium was increased in ITP and negatively correlated with platelet counts
-
Abstract Number: PB0336
Phenotypic and genetic features of thirteen families with variants in GP1BA, GP1BB and GP9 genes
-
Abstract Number: PB1264
Phenotypic heterogeneity within healthy donor endothelial colony forming cells explored by morphological analysis and RNA expression profiling
-
Abstract Number: OC 39.1
Phenotypic switch of platelet function from preterm to term neonates – daily life data from the Platelets In Neonatal Infants Study (PLINIUS)
-
Abstract Number: PB0363
Phosphoinositide dynamics in megakaryocyte/platelet granule integrity and platelet functions
-
Abstract Number: PB0466
Physician practice behaviors surrounding dose-reduction of direct oral anticoagulants for the extended phase treatment of venous thromboembolism
-
Abstract Number: VPB1384
Pilot Study of Effect on Thromboprophylaxis using System-wide Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized patients
-
Abstract Number: PB0392
Pim kinase: A novel regulator of platelet and megakaryocyte thromboxane A2 and C-X-C-R motif receptors
-
Abstract Number: PB1039
Plant heparinoids and their involvement in the regulation of blood coagulation
-
Abstract Number: OC 18.2
Plasma exosomes reflect myocardial injury detected by Cardiac Magnetic Resonance in STEMI patients
-
Abstract Number: PB1339
Plasma Levels of P-Selectin and Future Risk of Venous Thromboembolism
-
Abstract Number: PB0258
Plasma Lipoprotein(a) and Factor VIII levels after pediatric renal transplantation: a 10-year experience from a tertiary center in Brazil
-
Abstract Number: PB0935
Plasma MiRNAs and the Risk of Venous Thromboembolism in Patients with Glioblastoma: A Nested Case-control Study
-
Abstract Number: OC 43.4
Plasmin-cleaved VWF: a biomarker for microthrombosis
-
Abstract Number: PB0626
Plasminogen deficiency: a case series of an ultra-rare disease in a Spanish centre
-
Abstract Number: PB0083
Platelet activation and COVID-19 mortality: insights from coagulopathy, antiplatelet therapy and inflammation
-
Abstract Number: PB0769
Platelet Activation and Expression of CAR on Cardiomyocytes and Platelets: Implication on Inflammation in Patients with Dilated Cardiomyopathy
-
Abstract Number: PB0862
Platelet activation via glycoprotein VI initiates thrombin generation: a potential role for platelet-derived factor IX?
-
Abstract Number: PB0752
Platelet and immune cell cloaking of circulating tumour cells [CTCs] in breast and ovarian cancer
-
Abstract Number: PB0753
Platelet count as a novel diagnostic marker for early lung cancer diagnosis: an epidemiological study
-
Abstract Number: PB1212
Platelet desialylation status in adults with primary immune thrombocytopenia
-
Abstract Number: PB0855
Platelet dysfunction in HFpEF patients: plasma and whole blood measurements
-
Abstract Number: PB1246
Platelet Dysfunction in Inherited Thrombocytopenias with Predisposition to Hematologic Malignancies and its Correlation with Bleeding: Analysis of 23 Patients with RUNX1, ANKRD26, and EVT6 Mutations
-
Abstract Number: OC 77.3
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
-
Abstract Number: PB0887
Platelet function in MS-NASH mice: a newly developed obesity model
-
Abstract Number: PB0876
Platelet function testing and timing of bypass surgery – A platelet function sub-study from the RAPID CABG randomized trial
-
Abstract Number: PB0870
Platelet functional phenomics in the post-acute stage of pulmonary embolism
-
Abstract Number: OC 75.3
Platelet generation from circulating megakaryocytes is triggered in the lung vasculature
-
Abstract Number: PB0380
Platelet glycoprotein analysis by flow cytometry, could further diagnostic information be gained from the mean fluorescence intensity values?
-
Abstract Number: PB0388
Platelet glycoprotein Ibα carries ABO blood group antigens
-
Abstract Number: OC 72.1
Platelet HMGB1 mediates pathological NET formation in Ischemic Stroke
-
Abstract Number: PB0884
Platelet hyperaggregability in Framingham Heart Study participants living with obesity
-
Abstract Number: VPB0897
Platelet indices at the titanium rod implantation in rabbit femur
-
Abstract Number: PB0773
Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation
-
Abstract Number: PB0513
Platelet P2Y12 Receptor Polymorphism and Gene-Gene Interactions in Patients with High Cardiovascular Risk
-
Abstract Number: VPB0106
Platelet parameters in patients with COVID-19 and ST-elevation myocardial infarction
-
Abstract Number: VPB0778
Platelet proteomics reveals an inflammatory phenotype of platelets in type 2 diabetes
-
Abstract Number: OC 56.2
Platelet RalA/B play pivotal roles in regulation of venous thrombosis by co-ordinating P-selectin-HMGB1 interaction
-
Abstract Number: PB0883
Platelet reactivity and thrombogenicity in Framingham Heart Study participants with hypertriglyceridemia
-
Abstract Number: PB0852
Platelet reactivity is associated with arterial tonometry, vessel diameters and calcium burden
-
Abstract Number: PB0587
Platelet reactivity to SARS-CoV-2 Spike protein and domains.
-
Abstract Number: OC 75.5
Platelet release device: From bench-scale to large culture platelet production
-
Abstract Number: PB1194
Platelet Response to Avatrombopag Following Switch from Eltrombopag or Romiplostim in Primary vs. Secondary Immune Thrombocytopenia: A Multicenter Study of U.S. ITP Referral Centers
-
Abstract Number: OC 64.2
Platelet RNA sequencing and generation of an imMKCL-based cell model for SLFN14 K219N deficiency show evidence of increased cellular stress
-
Abstract Number: PB0851
Platelet secretion in wound healing: the essence of appropriate granule biogenesis
-
Abstract Number: PB1227
Platelet transfusion better preserves ROTEM clot strength and thrombin generation: a case-control study
-
Abstract Number: PB1259
Platelet α-granule content induces endothelial damage and blood brain barrier breakdown in experimental stroke
-
Abstract Number: OC 41.1
Platelet αIIbβ3 integrin is produced in different covalent forms that have different functions
-
Abstract Number: PB0190
Platelet-dependent factor VIII activity is more susceptible to inhibitor antibodies than phospholipid vesicle-dependent factor VIII activity
-
Abstract Number: VPB1298
Platelet-derived miRNAs and platelet-derived extracellular vesicles as emerging diagnostic and prognostic biomarkers in acute ischemic stroke patients
-
Abstract Number: PB0772
Platelet-Leukocyte Aggregates as Markers of (Pro)Thrombotic Inflammation
-
Abstract Number: OC 66.2
Platelet-mediated potentiation of the lung pre-metastatic niche in breast cancer
-
Abstract Number: OC 49.4
Platelet-released mitochondria interact with neutrophils, altering their phenotype and merging with the existing mitochondrial network
-
Abstract Number: VPB1223
Platelet-Specific CD8+ T Cells in Patients with Immune Thrombocytopenia
-
Abstract Number: VPB1425
Platelets And Neutrophils Co-Drive Procoagulant Potential in Antiphospholipid Syndrome During Pregnancy
-
Abstract Number: VPB0900
Platelets and von Willebrand factor after exposure to turbulent, but low shear flow with implications in mechanical circulatory support
-
Abstract Number: PB0751
Platelets are integral components of the tumor microenvironment whose regulatory actions vary with the tumor type
-
Abstract Number: LB 02.4
Platelets as Versatile Effectors of Thromboinflammation in Chronic Myeloproliferative Neoplasms
-
Abstract Number: PB0157
Platelets genetically modified with mRNA-lipid nanoparticles are functionally similar to clinically transfused platelets in vitro
-
Abstract Number: PB0771
Platelets promote neutrophil extracellular traps mediated thrombo-inflammation and glomerular endothelial dysfunction in diabetic kidney disease
-
Abstract Number: OC 32.2
Pleiotropic influence of rosuvastatin on apolipoproteins and their association with coagulation factor levels: results from the START trial
-
Abstract Number: PB0919
Polygenic risk scores for prediction of cancer-associated venous thromboembolism: a UK Biobank analysis
-
Abstract Number: PB0422
Polymeric prosthetic heart valves with low thrombogenicity
-
Abstract Number: VPB1312
Polymorphism of genes associated with fibrin clot structure or/and lysis rate could influence the risk of pulmonary embolism in young patients with venous thromboembolism
-
Abstract Number: PB1149
Pooled analysis of long-term efficacy and safety of simoctocog alfa in previously treated patients with haemophilia A
-
Abstract Number: VPB0945
Poor Performance Status and Elevated Factor VIII Levels Increase Thrombotic Risk in Lymphoma and Multiple Myeloma Patients
-
Abstract Number: PB0894
Population-based reference ranges of platelet function tests and their discriminative ability for cardiovascular disease
-
Abstract Number: PB1213
Possible targets to reduce fatigue in chronic immune thrombocytopenia patients – an explorative study
-
Abstract Number: PB0424
Post thrombotic syndrome: quality of life and incidence in patients under treatment with direct oral anticoagulants.
-
Abstract Number: PB1181
Post-Menopausal Bleeding and Arterial Thrombosis in Biological Females with Inherited Bleeding Disorders
-
Abstract Number: PB1182
Post-Operative Bleeding and Thrombosis in Biological Females with Inherited Bleeding Disorders: A Cross-Sectional Analysis from the Community Counts Registry
-
Abstract Number: PB0007
Post-partum Acquired Haemophilia A in the COVID era – building the case for Emicizumab?
-
Abstract Number: OC 52.3
Post-Partum Hemorrhage in Sub-Saharan Africa – First Results from a Prospective Study in Mozambique
-
Abstract Number: PO0043
Post-thrombotic hypercoagulation syndrome in patients with hemoblastoses
-
Abstract Number: PB0428
Post-thrombotic syndrome in patients with venous thromboembolism treated with rivaroxaban – Results from the FIRST Registry
-
Abstract Number: VPB1416
Postpartum Thromboprophylaxis Following Caesarean Delivery
-
Abstract Number: PB0966
Potential utility of a multi-component coagulation factor panel to detect portal vein thrombosis and assess hemostasis in chronic liver disease
-
Abstract Number: PB0397
PPAR-alpha inhibition of platelet activation and thrombosis
-
Abstract Number: PB1134
Practical utilisation of Octapharma FVIII concentrates in previously untreated and minimally treated haemophilia A patients entering routine clinical treatment – The Protect-NOW Study
-
Abstract Number: PB1178
Praxbind for reversal of Dabigatran: experience in a tertiary hospital
-
Abstract Number: PB1067
Pre-analytical screening and removal of Argatroban interference for Haemostasis assays
-
Abstract Number: VPB1373
Pre-Operative Thromboprophylaxis Does Not Cause Increased Bleeding Events in Patients with Surgically-Treated Hip Fractures
-
Abstract Number: PB0936
Pre-surgical ovarian vein thrombosis in women with ovarian malignancies as predictor of pulmonary embolism
-
Abstract Number: PO0059
Prechemotherapy D-Dimer Levels as Predictors of Response Treatment in Colorectal Cancer
-
Abstract Number: PB1114
Precision of One-Stage Clotting Factor Assays is Improved by Using Fresh Rather Than Stored Calibration Curves
-
Abstract Number: PB1005
Preclinical safety and toxicokinetics of VMX-C001 – an intravenous bypassing agent for factor Xa inhibitors
-
Abstract Number: PB1432
Predicting DVT Incidence based on risk factors by using Artificial Neural Networks
-
Abstract Number: PB1353
Predicting post-discharge venous thromboembolism and major bleeding among medical patients: External validation of a risk score derived from readily available laboratory tests.
-
Abstract Number: OC 65.1
Prediction of apixaban or rivaroxaban concentrations based on low molecular weight heparin anti-Xa activity using nomograms: a useful tool in emergency clinical situations like thrombolysis in stroke
-
Abstract Number: PB0502
Prediction of bleeding risk in patients with cancer receiving anticoagulants
-
Abstract Number: PO0009
Prediction of reccurent thrombotic events in survivors after COVID-19
-
Abstract Number: VPB0116
Prediction of severe covid, proposition of a severe index
-
Abstract Number: PB0959
Predictive factors for thrombophilia diagnosis: a single-center cross sectional study
-
Abstract Number: PB1320
Predictive factors of clot propagation towards deep venous thrombosis and/or pulmonary embolism in superficial venous thrombosis patients: a systematic review
-
Abstract Number: OC 27.5
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B (OPTI-CLOT TARGET study) – Preliminary results
-
Abstract Number: OC 08.4
Predictive risk factors for recurrent VTE in children
-
Abstract Number: VPB0139
Predictive value of D-dimer in Covid-19
-
Abstract Number: PB0049
Predictive value of Wells and Geneva score in suspected pulmonary thromboembolism in critically ill patients with COVID 19: A Retrospective Study
-
Abstract Number: VPB0205
Predictors of body mass index in persons with hemophilia over the life course: multisite, cross-sectional study (n=691)
-
Abstract Number: PB0267
Predictors of Catheter-related Arterial Thrombosis in Pediatric Patients After Cardiac Catheterization
-
Abstract Number: OC 39.2
Predictors of Platelet Function Disorders in Pediatric Patients
-
Abstract Number: PB1315
Predictors of Pregnancy Associated Venous Thromboembolism: A Case-Control Study
-
Abstract Number: PB0072
Predictors of venous thromboembolism in hospitalised COVID-19 positive patients
-
Abstract Number: PB0793
Preference for ravulizumab over eculizumab: a real-world patient preference and life impact study on the treatment of atypical hemolytic uremic syndrome
-
Abstract Number: PB1395
Pregnancy as a protective factor for bleeding in immune thrombocytopenia regardless of platelet count
-
Abstract Number: PB0706
Pregnancy in women with Factor XI deficiency ( < 60 UI/dL) and use of neuraxial analgesia : real life data in a French cohort of 314 pregnancies
-
Abstract Number: PB1408
Pregnancy-induced change in platelet transcription, metabolism, and aggregation: a longitudinal study from pre-pregnancy to postpartum
-
Abstract Number: PB0885
Pregnancy-specific glycoprotein 9 potentiates platelet function mediated by immunoreceptor tyrosine-based activation motif pathways
-
Abstract Number: PB0781
Prelatent and Native Antithrombin Effect on Cell Cycle and Proliferation of Glioblastoma Multiforme Cells
-
Abstract Number: OC 47.2
Prevalence and characteristics of non-neutralizing FVIII-specific antibodies in persons with hemophilia A – preliminary results
-
Abstract Number: VPB0737
Prevalence and Impact of Antiphospholipid Antibodies on Thrombotic Events in Ambulatory Cancer Patients
-
Abstract Number: OC 06.5
Prevalence and Severity of Bleeding Events in Thrombotic Antiphospholipid Syndrome – Should They be Included in the Damage Index for Antiphospholipid Syndrome?
-
Abstract Number: PB0102
Prevalence of cerebrovascular MRI markers in hospitalized patients with COVID-19
-
Abstract Number: PB0421
Prevalence of Guideline Discordant Aspirin use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement
-
Abstract Number: VPB0203
Prevalence of inhibitors in haemophilia patients: a study of 92 patients at the Annaba University Hospital Center in Algeria
-
Abstract Number: PB0248
Prevalence of iron deficiency anemia in children with hemophilia
-
Abstract Number: PB0195
Prevalence of Sporadic Haemophilia A: an updated analysis of two cohort studies
-
Abstract Number: PB1335
Prevalence of venous thromboembolism and its associations with demographics, disease spectrum and hydroxyurea use in a large racially homogenous population of sickle cell disease patients in Nigeria
-
Abstract Number: PB0924
Prevalence, treatment and prognosis of tumor thrombi in renal cell carcinoma
-
Abstract Number: OC 15.1
PREVAPIX-ALL: Phase 3 Study of the Safety and Efficacy of Apixaban for Thromboprophylaxis versus Standard of Care in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia or Lymphoma (ALL/LL)
-
Abstract Number: OC 38.4
Preventing CD62P-mediated leukocyte infiltration and activation enhances thrombus resolution in mice
-
Abstract Number: PO0033
Prevention of perioperative hemorrhage during open cardiac surgery in children with high titer inhibitor by Emicizumab combined with rhFVII：one case report
-
Abstract Number: VPB0033
Prevention of stroke and other thromboembolic events in primary care: alarming data from a Brazilian medium-size city
-
Abstract Number: PB0551
Prevention of tumor cell-induced coagulation activation by the small-molecule FXIa inhibitor, BMS-262084, is dependent on tissue factor (TF) expression levels
-
Abstract Number: PB0265
Prevention of Upper Extremity PICC-associated Thrombosis Using Squeeze Balls in the Inpatient Oncology Setting: Preliminary Findings from a Prospective Single-Arm Non-Randomized Investigation
-
Abstract Number: PB1359
Prevention of VTE in Hospitalized Patients with Acute Infectious Disease: Online CME Improves Physician Competence and Confidence
-
Abstract Number: PB0025
Primary hemostasis, coagulation and fibrinolysis markers in patients with intracranial large vessel occlusion stroke, on admission to hospital
-
Abstract Number: OC 26.1
Procoagulant Platelet – Neutrophil Interactions Exacerbate Ischemic Stroke
-
Abstract Number: OC 49.1
Procoagulant platelets have a distinct transcriptome that identifies the large GTPase dynamin as a driver in their formation
-
Abstract Number: VPB0583
Procoagulant Properties of Titanium and Titanium Nitride
-
Abstract Number: VPB0524
Procoagulatory Changes in Patients with Chronic Lower Limb Ischemia
-
Abstract Number: PB0186
Production of a Bispecific Monoclonal Antibody that Enhances Canine FIXa activation of Canine FX
-
Abstract Number: PB0354
Production of platelets in vitro in functionalised 3-dimensional scaffolds mimicking the bone marrow niche
-
Abstract Number: OC 60.4
Prognostic Model for Predicting the Risk of Symptomatic Venous Thromboembolism in Children and Adolescents with Lymphoma
-
Abstract Number: PB0585
Prognostic value of troponin elevation at admission and during monitoring in COVID-19 patients
-
Abstract Number: VPB1343
Prolonged Hypercoagulability Occurs Following Pelvic and Acetabular Fractures, as Defined by Serial Thrombelastography
-
Abstract Number: VPB1380
Prolonged Platelet-mediated Hypercoagulability Occurs Following Surgically Treated Hip Fractures
-
Abstract Number: VPB1382
Prolonged Post-operative Hypercoagulability Can be Defined Using Serial Thrombelastography in Patients with Metastatic Bone Disease
-
Abstract Number: PB0169
Proof of principle of a fast and fully automated FVIII functional inhibitor test
-
Abstract Number: VPB0329
Propensity Matched Comparison of Incidence and Outcomes of Heparin-Induce Thrombocytopenia in Patients Undergoing Percutaneous Cardiac Intervention vs Coronary Artery Bypass Grafting
-
Abstract Number: VPB0118
Proper algorithm in donor-recipient selection, the key to success in convalescent plasma treatment of Covid 19 patients
-
Abstract Number: PB0703
Prophylaxis with human coagulation factor X in an adolescent girl with hereditary major Stuart factor deficiency.
-
Abstract Number: PB0716
Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency During Surgery or Childbirth
-
Abstract Number: OC 19.5
Protease-Nexin-1,a serpin participating in neutrophil recruitment through CD11a integrin regulation.
-
Abstract Number: OC 28.4
Protective Role of Plasminogen Deficiency in Non-Alcoholic Fatty Liver Disease and Glucose Dysmetabolism
-
Abstract Number: OC 55.4
Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor by post-translational modification of functional arginine residues.
-
Abstract Number: VPB1421
Protein C and Antithrombin III of Pregnant Women Visiting Antenatal Clinic in University of Calabar Teaching Hospital, Calabar, Nigeria
-
Abstract Number: VPB0162
Protein Expression in Plasma after Hemarthrosis Differs Among Recombinant FVIII and FVIII-Fc Fusion Replacement in FVIII-Deficient Mice
-
Abstract Number: PB0165
Protein S Gla detects and attenuates early vascular calcification
-
Abstract Number: OC 38.1
Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury
-
Abstract Number: OC 35.3
Protein tyrosine phosphatase PTPN22 modulates platelet function and thrombosis
-
Abstract Number: OC 05.2
Proteome and phosphoproteome analyses of SARS-CoV-2-infected humanized K18-ACE2 mice reveal hyperactive phenotype of circulating platelets
-
Abstract Number: PB0756
Proteomic and functional profile of platelet-derived extracellular vesicles released under physiological and tumour-associated conditions
-
Abstract Number: PB0368
Proteomics demonstrate differences in protein lifespan regulation in platelets from adult and pediatric donors
-
Abstract Number: VPB0736
Prothrombin can modulate its expression in colon cancer cells
-
Abstract Number: OC 55.5
Prothrombin Circulates in Human Plasma in Multiple Covalent Forms with Differing Activities
-
Abstract Number: PB1094
Prothrombinase-induced clotting time for the measurement of rivaroxaban, apixaban, and edoxaban drug concentrations: a cross-sectional study
-
Abstract Number: PB1397
Psychological and cognitive factors involved in decision-making process of haemophilia carriers in reproductive choices
-
Abstract Number: PB1211
Psychological support for patients with Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) in Germany
-
Abstract Number: VPB0469
Pulmonary cement embolism after kyphoplasty: Clinical and Laboratory aspects of pro-coagulant effects
-
Abstract Number: PB0967
Pulmonary hemodynamics at rest and during exercise in patients with chronic thromboembolic pulmonary disease
-
Abstract Number: PB1294
Pulmonary thrombosis promotes sever flu in mice exposed to cigarette smoke.
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.